Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 14/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22010955 | 0.84 | RARB (0.40) | S1PR1MAPTRAB9AL3MBTL1 | |
| SCHEMBL22010835 | 0.83 | RARB (0.40) | MAPTRAB9AL3MBTL1 | |
| SCHEMBL22011104 | 0.81 | NAAA (0.33) | MAPTRAB9AL3MBTL1ALOX5THRB | |
| SCHEMBL22010998 | 0.80 | RARB (0.44) | S1PR1MAPTRAB9AL3MBTL1 | |
| SCHEMBL22011802 | 0.77 | CTSL (0.38) | MAPTALOX5THRBBLM | |
| SCHEMBL22010820 | 0.76 | RARB (0.40) | S1PR1 | |
| SCHEMBL22010811 | 0.76 | KDM4E (0.36) | MAPTALOX5 | |
| SCHEMBL22010968 | 0.76 | PGAM1 (0.42) | S1PR1L3MBTL1 | |
| SCHEMBL22011189 | 0.76 | RARB (0.37) | S1PR1MAPTRAB9AL3MBTL1 | |
| SCHEMBL22011788 | 0.74 | PGAM1 (0.42) | MAPTL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10662378-B2 | Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2020-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10662378-B2 | Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device | YBX1, ZKSCAN2, RCC1 | S1PR1 1710/4885MAPT 1234/4885RAB9A 2387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.